BDBM332509 4-(6-(tert-butoxycarbonylamino)-1-(2-chloro-6-(trifluoromethyl)benzoyl)-1H-pyrazolo[4,3-b]pyridin-3-yl)-3-fluorobenzoic acid (29A) and 4-(1-(2-chloro-6-(trifluoromethyl)benzoyl)-6-(methylamino)-1H-pyrazolo[4,3-b]pyridin-3-yl)-3-fluorobenzoic acid (29B)::US10196354, Example 29A::US9745265, 29A

SMILES CC(C)(C)OC(=O)Nc1cnc2c(nn(C(=O)c3c(Cl)cccc3C(F)(F)F)c2c1)-c1ccc(cc1F)C(O)=O

InChI Key InChIKey=WHGQARDUXBSUDH-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 332509   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM332509(4-(6-(tert-butoxycarbonylamino)-1-(2-chloro-6-(tri...)
Affinity DataIC50:  191nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent